Neil S. Belloff
CIK 1741670 · General Counsel and Corp Secy · last filed 2023-04-04
Neil S. Belloff is a General Counsel and Corp Secy who has filed 17 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for ACOR, was dated Apr 4, 2023. Current disclosed insider exposure totals $442.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$442.1K
2
17
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Acorda Therapeutics, Inc. (ACOR) Delisted | General Counsel and Corp Secy | — | $0.66 | — | $0 | 2 | 2023-04-04 |
| ELOX | COO, GENERAL COUNSEL &CORP SEC | 32,699 | $13.52 | $442.1K | $0 | 15 | 2021-07-30 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-04 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-09 | Acorda Therapeutics, Inc. (ACOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-30 | ELOX | Mixed | +1,104 | -$606 | EDGAR |
| 2021-05-26 | ELOX | Mixed | +4,415 | -$2.6K | EDGAR |
| 2021-05-03 | ELOX | Mixed | +1,103 | -$1.0K | EDGAR |
| 2021-02-26 | ELOX | Mixed | +17,662 | -$29.0K | EDGAR |
| 2021-02-17 | ELOX | Grant (A) | — | $0 | EDGAR |
| 2021-02-02 | ELOX | Mixed | +1,021 | -$1.9K | EDGAR |
| 2020-11-02 | ELOX | Mixed | +1,103 | -$1.2K | EDGAR |
| 2020-07-31 | ELOX | Mixed | +1,104 | -$1.3K | EDGAR |